Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Cancer|April 1, 1982
Phase II study of high-dose tamoxifen (NSC-180973) in patients with disseminated malignant melanomaE T Creagan, J N Ingle, D L Ahmann, et al.Oncology|January 1, 1977
A clinical trial adriamycin (NSC 123127) in advanced sarcomasE T Creagan, R G Hahn, D L Ahmann, et al.American Journal of Clinical Oncology|June 1, 1992
Phase II trial of recombinant tumor necrosis factor in disseminated malignant melanomaE R Feldman, E T Creagan, D J Schaid, et al.American Journal of Clinical Oncology|October 1, 1984
Phase II evaluation of L-alanosine (NSC-153353) for patients with disseminated malignant melanomaE T Creagan, H J Long, D L Ahmann, et al.Cancer Treatment Reports|December 1, 1982
Phase II study of an aziridinylbenzoquinone (AZQ) in disseminated malignant melanomaE T Creagan, A J Schutt, D L Ahmann, et al.Transfusion|July 1, 1989
Blood transfusion exposure does not influence survival in patients with carcinoma of the breastM E Kieckbusch, J R O'Fallon, D L Ahmann, et al.Cancer Chemotherapy Reports|June 1, 1972
Evaluation of cyclophosphamide (NSC-26271) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the treatment of patients with inoperable or disseminated lung cancerD L Ahmann, D T Carr, D T Coles, et al.American Journal of Clinical Oncology|June 1, 1990
Phase II assessment of recombinant leukocyte A interferon with difluoromethylornithine in disseminated malignant melanomaE T Creagan, H J Long, D L Ahmann, et al.Cancer Treatment Reports|June 1, 1982
Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanomaE T Creagan, D L Ahmann, A J Schutt, et al.Cancer|December 15, 1986
Recombinant leukocyte A interferon (rIFN-alpha A) in the treatment of disseminated malignant melanoma. Analysis of complete and long-term responding patientsE T Creagan, D L Ahmann, S Frytak, et al.Pageof 6